Co-Diagnostics Inc., a Salt Lake City-based molecular diagnostics company, has announced that its board of directors has appointed Richard Abbott as president, David Nielsen as chief operations officer (COO), Christopher Thurston as chief technology officer and Seth Egan as chief commercialization officer.
Prior to his new role at the company, Abbott was president of Advanced Conceptions Inc., a wholly owned subsidiary of Co-Diagnostics since December 2021, and has been instrumental in establishing the company’s teams and technology for its Co-Dx PCR platform. His experience includes over 25 years in Please log in to see the rest of this story.
